[EN] DIHYDROCHROMENOPYRAZOLE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS<br/>[FR] LIGANDS DES RÉCEPTEURS VANILLOÏDES
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2009010824A1
公开(公告)日:2009-01-22
The present invention relates to VR1 receptor ligands of the formula (I); and pharmaceutically acceptable salts, solvates, esters, stereoisomers, prodrugs, and N-oxides thereof. The present invention also relates to methods of treating diseases, conditions and/or disorders modulated by vanilloid receptors with these compounds, and processes for preparing them.
本发明涉及公式(I)的VR1受体配体;以及其药用盐、溶剂合物、酯、立体异构体、前药和N-氧化物。本发明还涉及使用这些化合物治疗由辣椒素受体调节的疾病、症状和/或障碍的方法,以及制备它们的过程。